Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 41: 419-423, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nissen, H.
Right arrow Articles by Horder, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nissen, H.
Right arrow Articles by Horder, M.

Clinical Chemistry, Vol 41, 419-423, Copyright © 1995 by American Association for Clinical Chemistry

Mutation screening of the codon 3500 region of the apolipoprotein B gene by denaturing gradient-gel electrophoresis

H Nissen, PS Hansen, O Faergeman and M Horder
Department of Clinical Chemistry, Odense University Hospital, Denmark.

Familial defective apolipoprotein B (FDB) is a clinical condition resembling familial hypercholesterolemia. The underlying genetic defects are mutations in the apolipoprotein B-100 (apo B-100) gene. Two mutations (Arg3500 --> Gln and Arg3531 --> Cys) are known to date. We designed a denaturing gradient-gel electrophoresis (DGGE) technique to detect sequence variations in codons 3456-3553 of the apo B-100 gene. In 46 heterozygous FDB patients with the predominant codon 3500 mutation, a uniform four-band DGGE pattern was seen, whereas 57 non-FDB patients showed the uniform single-band pattern expected in normal homozygotes. The recently described codon 3531 mutation and a previously unpublished Arg --> Pro mutation in codon 3480 showed unique DGGE patterns, allowing unambiguous differentiation of the three mutations. The DGGE method thus both detects known FDB mutations and screens for other mutations in codons 3456-3553 of the low-density lipoprotein receptor binding region of apo B-100; it can be used as a first-line screening method for FDB.


The following articles in journals at HighWire Press have cited this article:


Home page
 Ann Clin BiochemHome page
K. E Liyanage, A. J Hooper, J. C Defesche, J. R Burnett, and F. M van Bockxmeer
High-resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutations
Ann Clin Biochem, March 1, 2008; 45(2): 170 - 176.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Blesa, A. B. Garcia-Garcia, S. Martinez-Hervas, M. L. Mansego, V. Gonzalez-Albert, J. F. Ascaso, R. Carmena, J. T. Real, and F. J. Chaves
Analysis of Sequence Variations in the LDL Receptor Gene in Spain: General Gene Screening or Search for Specific Alterations?
Clin. Chem., June 1, 2006; 52(6): 1021 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Benn, B. G. Nordestgaard, J. S. Jensen, K. Nilausen, H. Meinertz, and A. Tybjaerg-Hansen
Mutation in Apolipoprotein B Associated with Hypobetalipoproteinemia Despite Decreased Binding to the Low Density Lipoprotein Receptor
J. Biol. Chem., June 3, 2005; 280(22): 21052 - 21060.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
M. A. Austin, C. M. Hutter, R. L. Zimmern, and S. E. Humphries
Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review
Am. J. Epidemiol., September 1, 2004; 160(5): 407 - 420.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Pawinski, M. Hale, M. Korecka, W. E. Fitzsimmons, and L. M. Shaw
Limited Sampling Strategy for the Estimation of Mycophenolic Acid Area under the Curve in Adult Renal Transplant Patients Treated with Concomitant Tacrolimus
Clin. Chem., September 1, 2002; 48(9): 1497 - 1504.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. Fisher, H. Scharnagl, M. M. Hoffmann, K. Kusterer, D. Wittmann, H. Wieland, W. Gross, and W. Marz
Mutations in the Apolipoprotein (apo) B-100 Receptor-binding region: Detection of apo B-100 (Arg3500->Trp) Associated with Two New Haplotypes and Evidence That apo B-100 (Glu3405->Gln) Diminishes Receptor-mediated Uptake of LDL
Clin. Chem., July 1, 1999; 45(7): 1026 - 1038.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. S. Nauck, H. Nissen, M. M. Hoffmann, J. Herwig, C. R. Pullinger, M. Averna, J. Geisel, H. Wieland, and W. Marz
Detection of mutations in the apolipoprotein CII gene by denaturing gradient gel electrophoresis. Identification of the splice site variant apolipoprotein CII-Hamburg in a patient with severe hypertriglyceridemia
Clin. Chem., July 1, 1998; 44(7): 1388 - 1396.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. G. Henderson, P. R. Wenham, J. P. Ashby, and G. Blundell
Detecting familial defective apolipoprotein B-100: three molecular scanning methods compared
Clin. Chem., September 1, 1997; 43(9): 1630 - 1634.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M.-L. Choong, E. S. C. Koay, K.-L. Khoo, M.-C. Khaw, and S. K. Sethi
Denaturing gradient-gel electrophoresis screening of familial defective apolipoprotein B-100 in a mixed Asian cohort: two cases of arginine3500 -> tryptophan mutation associated with a unique haplotype
Clin. Chem., June 1, 1997; 43(6): 916 - 923.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. N. Pimstone, J. C. Defesche, S. M. Clee, H. D. Bakker, M. R. Hayden, and J. J.P. Kastelein
Differences in the Phenotype Between Children With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia
Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 826 - 833.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.